Humanized
Drug Discovery

Welcome to Discovery Biomed
Integrating Human Cell Physiology with the Drug Discovery Critical Path.

Our Mission

DBM’s mission is to fill a critical niche within the modern drug discovery industry by specializing in custom human cell engineering and human cell-based drug discovery.

Our R&D infrastructure and know-how are leveraged as a CRO service to support the commercial and academic drug discovery community by integrating human cell research platforms at any and all points within the drug discovery critical path from HTS cell assay development and optimization to lead prioritization and progression, with the end product being ‘high value’ clinical candidates.

 

Latest News

Q2 2017 Update: DBM Sends Delegates to BIO and RESI Conferences in San Diego
July 10, 2017

As mentioned in the Q1 2017 update, it is an exciting year thus far for DiscoveryBioMed with the acquisition of a BioTek Cytation 5 anchored automated system. In order to…

Read More »
Q1 2017 Update: DBM Invests in Cytation 5 Anchored Automated System
May 24, 2017

Discovery BioMed prides itself on utilizing the latest technology platforms and offering services based on these advanced systems. In H1 2017 DBM invested in a BioTek Cytation 5 anchored automatic…

Read More »

Online Store

Human Cellular Toxicity Assay Panels

Learn More

Human Cell Cultures, Cell Lines and Specialty Media and Methods

Learn More

Custom CRO Services Program

Learn More